ATTD-ASIA 2026: Diabetes Conference, 9-11 December

Join us in Kyoto for the highly anticipated 3rd Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2026), where cutting-edge diabetes research and innovative technologies take center stage on 9-11 December 2026. This conference is an exclusive platform designed for the Asian diabetes community, showcasing the latest advancements in therapies and management techniques tailored to the unique needs of the region.

ATTD-ASIA is more than just an event; it’s a conversation by Asia, for Asia. We are fostering a collaborative dialogue between the East and West, highlighting how advancements in diabetes care can be integrated into the Asian market. Expect thought-provoking discussions, groundbreaking research, and new opportunities to drive forward diabetes management practices.

At ATTD-ASIA 2026, language is not a barrier. AI-powered English-to-Japanese translation will be available for all sessions throughout the program, allowing our Japanese-speaking attendees to follow presentations, discussions, and scientific content in real time. Don’t miss a moment of the science.

As a clinician, you are a healthcare professional who specializes in diagnosing, managing, and treating diabetes and its related complications

As a diabetes care provider, you help diagnose, manage, and treat diabetes through personalized care. You educate patients on blood sugar control, lifestyle modifications, and medication use while addressing complications. Your role spans clinical treatment, technology integration, and collaborative care with a multidisciplinary team.

As a researcher you investigate the causes, treatments, and prevention of diabetes through clinical and laboratory studies. You analyze data, test new therapies, and explore advancements in technology, genetics, and lifestyle interventions. Your work contributes to developing innovative treatments, improving patient outcomes, and shaping future guidelines.